Andreas Halvorsen - Viking Global Investors
Holding/activity history for ORIC Pharmaceuticals Inc. (ORIC)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 5,824,533 | 0.21 | Reduce 11.38% | 0.02 | $12.67 | $73,796,833 | SEC |
| 2025 Q4 | 6,572,691 | 0.14 | Reduce 0.00% | $8.18 | $53,764,612 | SEC | |
| 2025 Q3 | 6,572,700 | 0.20 | $12.00 | $78,872,400 | SEC | ||
| 2025 Q2 | 6,572,700 | 0.19 | $10.15 | $66,712,905 | SEC | ||
| 2025 Q1 | 6,572,700 | 0.12 | Add 48.33% | 0.04 | $5.58 | $36,675,666 | SEC |
| 2024 Q4 | 4,431,008 | 0.12 | Add 10.78% | 0.01 | $8.07 | $35,758,235 | SEC |
| 2024 Q3 | 4,000,000 | 0.15 | $10.25 | $41,000,000 | SEC | ||
| 2024 Q2 | 4,000,000 | 0.11 | $7.07 | $28,280,000 | SEC | ||
| 2024 Q1 | 4,000,000 | 0.20 | Buy | 0.20 | $13.75 | $55,000,000 | SEC |